Effects of glucagon-like peptide-1 analog liraglutide on the systemic inflammation in high-fat-diet-induced mice

被引：0
|
作者：
Sha Sha
Xiaoming Liu
Ruxing Zhao
Li Qing
Qin He
Lei Sun
Li Chen
机构：
[1] Qilu Hospital of Shandong University,Department of Endocrinology
[2] Institute of Endocrine and Metabolic Diseases of Shandong University,Key Laboratory of Endocrine and Metabolic Diseases
[3] Shandong Province medicine& health,undefined
来源：
Endocrine | 2019年 / 66卷
关键词：
Obesity; Immune; GLP-1; Metabolic syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：494 / 502
页数：8
相关论文
共 50 条
  • [31] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [32] Chronic high fat diet impairs glucagon like peptide-1 sensitivity in vagal afferents
    Al Helaili, Alaa
    Park, Sung Jin
    Beyak, Michael J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (01) : 110 - 117
  • [33] Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
    El Bekay, Rajaa
    Coin-Araguez, Leticia
    Fernandez-Garcia, Diego
    Oliva-Olivera, Wilfredo
    Bernal-Lopez, Rosa
    Clemente-Postigo, Mercedes
    Delgado-Lista, Javier
    Diaz-Ruiz, Alberto
    Guzman-Ruiz, Rocio
    Vazquez-Martinez, Rafael
    Lhamyani, Said
    Mar Roca-Rodriguez, Maria
    Fernandez Veledo, Sonia
    Vendrell, Joan
    Malagon, Maria M.
    Jose Tinahones, Francisco
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (11) : 1820 - 1834
  • [34] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [35] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [36] The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome
    Senda, Miho
    Ogawa, Susumu
    Nako, Kazuhiro
    Okamura, Masashi
    Sakamoto, Takuya
    Ito, Sadayoshi
    ENDOCRINE JOURNAL, 2012, 59 (10) : 889 - 894
  • [37] Equine glucagon-like peptide-1 receptor physiology
    Kheder, Murad H.
    Bailey, Simon R.
    Dudley, Kevin J.
    Sillence, Martin N.
    de Laat, Melody A.
    PEERJ, 2018, 6
  • [38] The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
    Abu-Hamdah, Rania
    Rabiee, Atoosa
    Meneilly, Graydon S.
    Shannon, Richard P.
    Andersen, Dana K.
    Elahi, Dariush
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06) : 1843 - 1852
  • [39] Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy
    Wen, Yuetao
    Wu, Kunlun
    Xie, Yanfeng
    Dan, Wei
    Zhan, Yan
    Shi, Quanhong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 511 (01) : 79 - 86
  • [40] The Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Reduces Inflammation and Improves Cardiac Function in a Mouse Model of Obesity
    Noyan-Ashraf, Mohammad Hossein
    Billia, Filio
    Mukovozov, Ilya M.
    Robinson, Lisa A.
    Volchuk, Allen
    Drucker, Daniel J.
    Husain, Mansoor
    CIRCULATION, 2010, 122 (21)
12345